Chan Wook Woo

Summary

Affiliation: Korea University
Country: Korea

Publications

  1. ncbi request reprint Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma
    Chan Wook Woo
    Department of Pediatrics, College of Medicine, Korea University, Seoul 152 703, South Korea
    Pediatr Blood Cancer 50:208-12. 2008
  2. ncbi request reprint Predictive risk factors for coronary artery abnormalities in Kawasaki disease
    Taeyeun Kim
    Department of Pediatrics, Korea University College of Medicine, Seoul, South Korea
    Eur J Pediatr 166:421-5. 2007
  3. ncbi request reprint NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number
    Chan Wook Woo
    Cell and Molecular Biology Section, Pediatric Oncology Branch, NCI, NIH, Bethesda, MD 20892, USA
    Oncogene 23:1522-30. 2004
  4. pmc Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma
    Liping Song
    Division of Hematology Oncology, Department of Pediatrics, Childrens Hospital Los Angeles CHLA, Los Angeles, California 90027, USA
    J Clin Invest 117:2702-12. 2007
  5. ncbi request reprint Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity
    Melinda S Merchant
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Natl Cancer Inst 94:1673-9. 2002
  6. ncbi request reprint Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells
    Katsuya Nakamura
    Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
    Cancer Res 66:4249-55. 2006

Collaborators

  • Melinda S Merchant
  • CHARLES PATRICK REYNOLDS
  • Taeyeun Kim
  • Liping Song
  • Carol J Thiele
  • Katsuya Nakamura
  • Robert C Seeger
  • KwangChul Lee
  • Byungmin Choi
  • Tasnim Ara
  • Hong wei Wu
  • Changsung Son
  • Leonid S Metelitsa
  • Richard Sposto
  • Wooksun Choi
  • Yves A DeClerck
  • Joowon Lee
  • JungHwa Lee
  • Kiichiro Beppu
  • Kelly C Martin
  • Jennifer K Jackson

Detail Information

Publications6

  1. ncbi request reprint Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma
    Chan Wook Woo
    Department of Pediatrics, College of Medicine, Korea University, Seoul 152 703, South Korea
    Pediatr Blood Cancer 50:208-12. 2008
    ..However, it was still unclear which were MYCN dependent effects or not...
  2. ncbi request reprint Predictive risk factors for coronary artery abnormalities in Kawasaki disease
    Taeyeun Kim
    Department of Pediatrics, Korea University College of Medicine, Seoul, South Korea
    Eur J Pediatr 166:421-5. 2007
    ..Early identification of IVGG non-responders and active therapeutic intervention for fever in KD cases might decrease the incidence of CAA...
  3. ncbi request reprint NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number
    Chan Wook Woo
    Cell and Molecular Biology Section, Pediatric Oncology Branch, NCI, NIH, Bethesda, MD 20892, USA
    Oncogene 23:1522-30. 2004
    ..Furthermore, NGF affects the time required for 15N TrkA cells to complete a replication cycle by decreasing N-myc, E2Fs, cyclin E kinase activity and increasing p27(kip1) binding to cyclin E kinase...
  4. pmc Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma
    Liping Song
    Division of Hematology Oncology, Department of Pediatrics, Childrens Hospital Los Angeles CHLA, Los Angeles, California 90027, USA
    J Clin Invest 117:2702-12. 2007
    ....
  5. ncbi request reprint Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity
    Melinda S Merchant
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Natl Cancer Inst 94:1673-9. 2002
    ..We thus examined whether the specific tyrosine kinase inhibitor imatinib mesylate (hereafter imatinib; formerly STI571) could inhibit the proliferation of Ewing's sarcoma cells in vitro and in vivo...
  6. ncbi request reprint Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells
    Katsuya Nakamura
    Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
    Cancer Res 66:4249-55. 2006
    ....